A low-cost hospital-based exercise program improved pain, balance, and overall well-being in participants with osteoarthritis. The study showed a significant reduction in pain intensity and improvement in daily activities.
New research suggests that statins can decrease inflammatory and thrombotic proteins in individuals with antiphospholipid antibodies, reducing the risk of blood clots and other complications. A prospective study found that fluvastatin significantly decreased protein levels in patients with APS, offering a potential new treatment option.
A new study estimates that antiphospholipid antibodies are associated with pregnancy loss, stroke, myocardial infarction, and deep vein thrombosis in up to 60,000 cases each. The research provides a rough snapshot of the prevalence of autoimmune antiphospholipid antibodies in patients with various health conditions.
A new study by Hospital for Special Surgery has revealed that corticosteroids are more effective than the expensive treatment hylan G-F 20 in providing pain relief to patients with thumb arthritis. Clinically meaningful pain relief was achieved with all three treatments, including a placebo injection.
Studies found that lupus patients who underwent knee replacement surgery experienced few adverse events, with outcomes similar to those of osteoarthritis patients. Rheumatoid arthritis (RA) patients also performed similarly after joint replacement surgery, with no significant differences in operation time or post-surgical complications.
Researchers found that rheumatoid arthritis patients are at higher risk for cancer, broken bones increase cardiovascular disease and death, and corticosteroids remain a common treatment despite newer options. Gut bacteria also holds promise as an anti-inflammatory treatment for autoimmune disorders.
Patients who make $35,000 a year or less show improved pain management and knee function after two years following knee replacement surgery. Contrary to expectations, lower-income patients exhibit better outcomes than wealthier peers.
A new study by Hospital for Special Surgery reveals that morbidly obese patients have similar pain and function outcomes to non-obese patients after total knee replacement surgery. The research challenges the long-held assumption that obesity is a contraindication to joint replacement, with patients achieving great outcomes.